Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
199.38
+0.11 (0.06%)
Sep 10, 2024, 11:21 AM EDT - Market open

Biogen Market Cap

Biogen has a market cap or net worth of $29.04 billion as of September 10, 2024. Its market cap has decreased by -23.59% in one year.

Market Cap
29.04B
Enterprise Value
33.78B
1-Year Change
-23.59%
Ranking
Category
Stock Price
$199.38

Market Cap Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $29.04B, an increase of 4,603.16%. That is a compound annual growth rate of 16.10%.

History

DateMarket Cap% Change
Sep 9, 202429.03B-22.59%
Dec 29, 202337.50B-5.97%
Dec 30, 202239.88B13.15%
Dec 31, 202135.24B-6.47%
Dec 31, 202037.68B-29.63%
Dec 31, 201953.54B-11.69%
Dec 31, 201860.63B-10.00%
Dec 29, 201767.37B9.19%
Dec 30, 201661.70B-9.65%
Dec 31, 201568.29B-14.82%
Dec 31, 201480.16B21.39%
Dec 31, 201366.04B90.69%
Dec 31, 201234.63B29.54%
Dec 30, 201126.73B67.31%
Dec 31, 201015.98B3.27%
Dec 31, 200915.47B11.34%
Dec 31, 200813.90B-16.78%
Dec 31, 200716.70B0.70%
Dec 29, 200616.58B7.90%
Dec 30, 200515.37B-30.83%
Dec 31, 200422.22B288.89%
Dec 31, 20035.71B12.55%
Dec 31, 20025.08B-51.71%
Dec 31, 200110.51B21.91%
Dec 29, 20008.62B107.47%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Veeva Systems 35.99B
argenx SE 32.94B
Alnylam Pharmaceuticals 32.32B
Moderna 29.79B
Mettler-Toledo International 29.47B
Koninklijke Philips 28.09B
Cardinal Health 27.91B
DexCom 27.50B
Market Cap Rankings